BriaCell Therapeutics
Jamieson Bondarenko is an active investor and provides strategic capital markets & corporate development advice to early-stage life sciences companies through his merchant capital company, JGRNT Capital Corp. Jamieson was most recently Principal, Managing Director, Equity Capital Markets at Eight Capital. His previous roles include Equity Capital Markets and Investment Banking positions at Dundee Capital Markets, Wellington West Capital Markets, and HSBC Securities.
Jamieson is a CFA Charterholder and a Chartered Market Technician.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
BriaCell Therapeutics
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V: BCT) is a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer.